The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Advances in Oncology Therapeutics
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Advances in Oncology Therapeutics.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Advances in Oncology Therapeutics.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Advances in Oncology Therapeutics are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
19. International Conference on Advances in Oncology Therapeutics has teamed up with the Special Journal Issue on
Advances in Oncology Therapeutics.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
A Study on the Application of Machine Learning and Deep Learning Techniques for Skin Cancer Detection
Hritwik Ghosh, Irfan Sadiq Rahat, Sachi Nandan Mohanty, J. V. R. Ravindra, Abdus Sobur
-
Awareness for Air Pollution Impacts on Lung Cancer in Southern California: A Pilot Study for Designed Smartphone Application
M. Mohammed Raoof, A. Enkhtaivan, H. Aljuaid
-
Dry Binder Mixing of Field Trial Investigation Using Soil Mix Technology: A Case Study on Contaminated Site Soil
M. Allagoa, A. Al-Tabbaa
-
Attention Multiple Instance Learning for Cancer Tissue Classification in Digital Histopathology Images
Afaf Alharbi, Qianni Zhang
-
Probe-Assisted Axillary Lymph Node Biopsy Compared with Axillary Dissection in Breast Cancer: A Retrospective Study from the West of Iran
Morteza Alizadeh Foroutan, Hassan Moayeri, Keivan Sabooni, Motahareh Rouhi Ardeshiri
-
Breast Cancer Prediction Using Score-Level Fusion of Machine Learning and Deep Learning Models
[email protected]
-
The Effect of Aerobic Training and Taxol Consumption on IL 8 and PAI-1 in Cervical Cancer
Alireza Barari, Maryam Firoozi, Maryam Ebrahimzadeh, Romina Roohani Ardeshiri, Maryam Kamarloeei
-
Classification of Potential Biomarkers in Breast Cancer Using Artificial Intelligence Algorithms and Anthropometric Datasets
Aref Aasi, Sahar Ebrahimi Bajgani, Erfan Aasi
-
Attitudes of Gratitude: An Analysis of 30 Cancer Narratives Published by Leading U.S. Cancer Care Centers
Maria L. McLeod
-
Zinc Oxide Nanoparticles Modified with Galactose as Potential Drug Carrier with Reduced Releasing of Zinc Ions
Jolanta Pulit-Prociak, Olga Długosz, Marcin Banach
-
‘Memory Mate’ as Boundary Object in Cancer Treatment for Patients with Dementia
Rachel Hurdley, Jane Hopkinson
-
A Convolutional Deep Neural Network Approach for Skin Cancer Detection Using Skin Lesion Images
Firas Gerges, Frank Y. Shih
-
Automated 3D Segmentation System for Detecting Tumor and Its Heterogeneity in Patients with High Grade Ovarian Epithelial Cancer
D. A. Binas, M. Konidari, C. Bourgioti, L. Angela Moulopoulou, T. L. Economopoulos, G. K. Matsopoulos
-
Multiple Approaches for Ultrasonic Cavitation Monitoring of Oxygen-Loaded Nanodroplets
Simone Galati, Adriano Troia
-
Integrated Social Support through Social Networks to Enhance the Quality of Life of Metastatic Breast Cancer Patients
B. Thanasansomboon, S. Choemprayong, N. Parinyanitikul, U. Tanlamai
Digital Program consists of the e-proceedings book which is available online-only
and includes the conference communications (proceedings abstracts and papers).
Registered participants can access the digitally available conference
proceedings ( and certificates ) by visiting their profile pages.
Drug delivery systems for cancer
Metal-based prodrugs as a strategy for drug delivery
Tumor-specific drug delivery systems and tumor-targeting chemotherapy
Multidrug delivery
Nanoformulations containing peptide-drug conjugation agents for tumor targeting
Delivery strategies according to cancer type and location
Armed monoclonal therapeutics
Nanodrug particles based on antisense, RNAi, siRNA, antibodies, and natural products
Combined strategies directed against tumoral endothelium
Mathematical modeling of drug delivery
Therapeutics exploiting cancer-cell transporters
Decoy therapeutics that achieve unsuspected cellular entry
MRI-guided focused ultrasound as a new method of drug delivery
Abstracts/Full-Text Paper Submission Deadline |
|
November 28, 2024 |
Notification of Acceptance/Rejection |
|
December 12, 2024 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
December 14, 2024 |
Conference Dates |
|
January 30-31, 2025 |